Amblyopia Treatment Market

Amblyopia Treatment Market

  • HC-6492
  • 4.9 Rating
  • 211 Pages
  • Upcoming
  • 98 Reviews
  • PDF Excel PPT
raksha

Author :

Raksha Sharma

Vineet

Fact-checked by :

Vineet Pandey

Vishal

Editor :

Vishal Golekar

Amblyopia Treatment Market Outlook 2032

The global amblyopia treatment market size was USD 3.8 Billion in 2023 and is projected to reach USD 5.46 Billion by 2032, expanding at a CAGR of 4.1% during 2024–2032. The market growth is attributed to the growing demand for amblyopia treatment solutions.

Amblyopia Treatment Market Outlook

Increasing awareness about the importance of early intervention in vision disorders is resulting in the growing demand for amblyopia treatments, which further boosts the market. These treatments are increasingly utilized in vision recovery centers, eye hospitals, and telemedicine platforms, catering to a diverse consumer base. Furthermore, a growing number of people experiencing vision impairments propels the market during the forecast period.

  • According to the report published by WHO on August 10, 2023, around 2.2 billion individuals are suffering from distance vision impairment globally.

Impact of Artificial Intelligence (AI) in Amblyopia Treatment Market

The use of artificial intelligence is likely to boost the amblyopia treatment market. AI-powered algorithms analyze vast amounts of patient data to identify subtle patterns and indicators of amblyopia with accuracy. Furthermore, AI-enabled telemedicine platforms have expanded access to amblyopia care, particularly in underserved areas, by facilitating remote consultations and monitoring.

Amblyopia Treatment Market Dynamics

Amblyopia Treatment Market Dynamics

Major Drivers

Increasing prevalence of amblyopia is anticipated to drive the market during the forecast period. Factors such as excessive screen time and changing lifestyles create a need for effective treatment solutions for eye disorders. For instance, as per the report published by the National Eye Institute on September 22, 2022, amblyopia is a vision disorder that typically begins in childhood and affects up to 3 out of every 100 children globally. Moreover, government initiatives aimed at promoting early diagnosis and intervention are expected to further fuel the demand for amblyopia treatment in the coming years.

Existing Restraints

High treatment costs are anticipated to hinder the market during the forecast period. The cost of amblyopia treatment includes expenses related to consultations with ophthalmologists, diagnostic tests, such as visual acuity testing, and imaging studies. Moreover, the limited accessibility to specialized healthcare facilities and trained professionals for amblyopia in remote location further hampers the market.

Emerging Opportunities

­­Rising investment in research and development (R&D) activities is expected to create immense opportunities for the players competing in the market in the coming years. Manufacturers are aiming to allocate substantial resources toward the development of innovative apparatus technologies and modalities for amblyopia. Furthermore, the integration of telehealth and remote monitoring in these devices to treat remotely is boosting the market.

Scope of the Amblyopia Treatment Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.

Attributes

Details

Report Title

Amblyopia Treatment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2023

Historic Data

2017 -2022

Forecast Period

2024–2032

Segmentation

Treatment Type (Spectacle Lenses, Eye Patches, Eye Drops & Ointments, Surgery, and Others), Distribution Channel (Pharmacies, Hypermarkets & Supermarkets, Drug Store, E-commerce, and Others), and End-user (Hospitals, Clinical Laboratories, Physician Offices, Reference Laboratories, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast

Key Players Covered in the Report

3M; Good-Lite Co; Healio; HOYA; Johnson & Johnson Services, Inc; Lancastle International Ltd; NovaSight; Ortopad USA.Com; RevitalVision; Trayner Staffing LLC; and Vivid Vision, Inc.


Regional Outlook

In terms of region, the global amblyopia treatment market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America held a major market share in 2023, due to the well-established healthcare systems and increasing initiatives to promote early diagnosis & treatment of amblyopia. Moreover, the rising population suffering from vision impairments in this region further boosts the demand for amblyopia treatments in various healthcare settings.

  • According to a report published by the Centers for Disease Control and Prevention on December 19, 2022, around 12 million the US-citizens aged 40 years or older are suffering with vision impairment. Furthermore, nearly 6.8% of children under 18 in the US have been diagnosed with eye and vision conditions.

The market in Asia Pacific is projected to grow at a significant pace in the coming years, owing to improved access to healthcare services, such as amblyopia treatment solutions. Furthermore, increasing healthcare access in rural areas, and promoting diagnosis and treatment of vision disorders are anticipated to fuel the market in the region during the forecast period.

Amblyopia Treatment Market Region

Amblyopia Treatment Market Segment Insights

Treatment Type Segment Analysis

Based on treatment type, the amblyopia treatment market is divided into spectacle lenses, eye patches, eye drops & ointments, surgery, and others. The eye patches segment held a major share of the market in 2023, due to their widespread adoption as a standard treatment modality for amblyopia, especially in pediatric patients.

Eye patches are commonly used to occlude the stronger eye, thereby encouraging the weaker eye to function and develop properly. Moreover, the non-invasive nature of occlusion therapy and its minimal side effects further boost their demand.

The eye drops & ointments segment is expected to expand at a significant growth rate in the coming years, owing to the advancements in pharmacological interventions and the introduction of innovative treatment options. Pharmaceutical companies are increasingly focusing on developing novel formulations, targeting specific mechanisms underlying amblyopia pathogenesis such as visual cortex plasticity and neurotransmitter regulation. Moreover, the convenience and efficacy of pharmacological treatments are likely to appeal to both patients and healthcare providers, thereby fueling the adoption of eye drops and ointments.

Amblyopia Treatment Market Treatment Type

Distribution Channel Segment Analysis

On the basis of distribution channel, the global market is segregated into pharmacies, hypermarkets & supermarkets, drug store, e-commerce, and others. The e-commerce segment is anticipated to expand at a substantial CAGR during the forecast period, as they offer unparalleled convenience, allowing patients to browse, purchase, and receive products from the comfort of their homes. Moreover, the expansive reach of e-commerce platforms enables patients in remote or underserved areas to access diverse amblyopia treatment options. These factors further boost the segment during the forecast period.

Amblyopia Treatment Market Distribution Channel

End-user Segment Analysis

On the basis of end-user, the market is divided into hospitals, clinical laboratories, physician offices, reference laboratories, and others. The hospitals segment generated a major revenue share of the market in 2023, due to their advanced infrastructure and access to specialized ophthalmic equipment and expertise.  Furthermore, hospitals often serve as referral centers for complex cases of amblyopia, attracting patients seeking specialized care and advanced treatment options. These all factors contributes to the growing demand for amblyopia treatment in these types of healthcare settings.

The physician offices segment is expected to lead the market in terms of revenue during the projection period, owing to the growing patient pool towards these type of healthcare settings. Physician offices offer accessible and personalized amblyopia care experience for patients. Moreover, the growing emphasis on preventive care and early intervention in vision disorders is likely to boost the demand for amblyopia treatment in physician offices.

Segments

The amblyopia treatment market has been segmented on the basis of

Treatment Type

  • Spectacle Lenses
  • Eye Patches
  • Eye Drops & Ointments
  • Surgery
  • Others

Distribution Channel

  • Pharmacies
  • Hypermarkets & Supermarkets
  • Drug Store
  • E-commerce
  • Others

End-user

  • Hospitals
  • Clinical Laboratories
  • Physician Offices
  • Reference Laboratories
  • Others

Region

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • 3M
  • Good-Lite Co
  • Healio
  • HOYA
  • Johnson & Johnson Services, Inc
  • Lancastle International Ltd
  • NovaSight
  • Ortopad USA.Com
  • RevitalVision
  • Trayner Staffing LLC
  • Vivid Vision, Inc

Competitive Landscape

Key players competing in the global amblyopia treatment market are 3M; Good-Lite Co; Healio; HOYA; Johnson & Johnson Services, Inc; Lancastle International Ltd; NovaSight; Ortopad USA.Com; RevitalVision; Trayner Staffing LLC; and Vivid Vision, Inc

These companies use development strategies including mergers, acquisitions, partnerships, collaboration, and product launches to expand their consumer base worldwide. For instance,

  • On October 24, 2022, Healio, a medical equipment manufacturer, received clearance from FDA 510(k) for its digital therapy devices for amblyopia. These treatment glasses are meant to replace traditional eye patching and are used in home settings. The technology uses eye-tracking to train both eyes to work together.

    Amblyopia Treatment Market Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Amblyopia Treatment Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Amblyopia Treatment Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Amblyopia Treatment Market - Supply Chain
  4.5. Global Amblyopia Treatment Market Forecast
     4.5.1. Amblyopia Treatment Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Amblyopia Treatment Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Amblyopia Treatment Market Absolute $ Opportunity
5. Global Amblyopia Treatment Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Amblyopia Treatment Market Size and Volume Forecast by End Users
     5.3.1. Hospitals
     5.3.2. Clinical Laboratories
     5.3.3. Physician Offices
     5.3.4. Reference Laboratories
     5.3.5. Others
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Amblyopia Treatment Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Amblyopia Treatment Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Amblyopia Treatment Demand Share Forecast, 2019-2026
7. North America Amblyopia Treatment Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Amblyopia Treatment Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Amblyopia Treatment Market Size and Volume Forecast by End Users
     7.4.1. Hospitals
     7.4.2. Clinical Laboratories
     7.4.3. Physician Offices
     7.4.4. Reference Laboratories
     7.4.5. Others
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Amblyopia Treatment Demand Share Forecast, 2019-2026
8. Latin America Amblyopia Treatment Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Amblyopia Treatment Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Amblyopia Treatment Market Size and Volume Forecast by End Users
     8.4.1. Hospitals
     8.4.2. Clinical Laboratories
     8.4.3. Physician Offices
     8.4.4. Reference Laboratories
     8.4.5. Others
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Amblyopia Treatment Demand Share Forecast, 2019-2026
9. Europe Amblyopia Treatment Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Amblyopia Treatment Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Amblyopia Treatment Market Size and Volume Forecast by End Users
     9.4.1. Hospitals
     9.4.2. Clinical Laboratories
     9.4.3. Physician Offices
     9.4.4. Reference Laboratories
     9.4.5. Others
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Amblyopia Treatment Demand Share Forecast, 2019-2026
10. Asia Pacific Amblyopia Treatment Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Amblyopia Treatment Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Amblyopia Treatment Market Size and Volume Forecast by End Users
     10.4.1. Hospitals
     10.4.2. Clinical Laboratories
     10.4.3. Physician Offices
     10.4.4. Reference Laboratories
     10.4.5. Others
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Amblyopia Treatment Demand Share Forecast, 2019-2026
11. Middle East & Africa Amblyopia Treatment Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Amblyopia Treatment Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Amblyopia Treatment Market Size and Volume Forecast by End Users
     11.4.1. Hospitals
     11.4.2. Clinical Laboratories
     11.4.3. Physician Offices
     11.4.4. Reference Laboratories
     11.4.5. Others
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Amblyopia Treatment Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Amblyopia Treatment Market: Market Share Analysis
  12.2. Amblyopia Treatment Distributors and Customers
  12.3. Amblyopia Treatment Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. 3M
     12.4.2. Good-Lite Co
     12.4.3. Healio
     12.4.4. HOYA
     12.4.5. Johnson & Johnson Services, Inc
     12.4.6. Lancastle International Ltd
     12.4.7. NovaSight
     12.4.8. Ortopad USA.Com
     12.4.9. RevitalVision
     12.4.10. Trayner Staffing LLC
     12.4.11. Vivid Vision, Inc

Purchase Premium Report